Chemomab Therapeutics Ltd.

CMMB ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Mar 31, 2026
20-F Mar 23, 2026 20-F
6-K Mar 20, 2026 6-K
6-K Mar 19, 2026 6-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 10, 2026
6-K Nov 21, 2025 6-K
6-K Aug 22, 2025 6-K
6-K Aug 14, 2025 6-K
SCHEDULE 13G/A Aug 11, 2025
SCHEDULE 13G/A Aug 7, 2025
SCHEDULE 13G Aug 7, 2025
6-K Jul 25, 2025 6-K
424B5 Jul 25, 2025 424B5
6-K Jul 1, 2025 6-K
SCHEDULE 13D/A Jun 23, 2025
6-K May 27, 2025 6-K
6-K May 15, 2025 6-K
6-K Apr 15, 2025 6-K
SCHEDULE 13G/A Apr 10, 2025
20-F Apr 4, 2025 20-F
6-K Mar 27, 2025 6-K
6-K Mar 20, 2025 6-K
6-K Mar 3, 2025 6-K
6-K Feb 19, 2025 6-K
← Newer Page 2 of 15 · 362 filings Older →